Patent · US Active

Human antibodies specifically binding to the hepatitis B virus surface antigen

US9200062B2 · kind B2 · utility

1Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 21, 2014
Grant dateDec 1, 2015
Priority date—
Expiry dateMay 21, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are antibodies specifically binding to the HBV surface antigen (HBsAg) which are effective for the prevention or treatment of hepatitis B.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.